Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The restricted cubic spline curve of serum uric acid levels also showed an increased risk of mortality with decreased serum uric acid levels (Fig. 1).Cox hazard regression analysis for all-cause mortality by serum uric acid levelSerum uric acid level (mg/dl)Quartile 1Quartile 2Quartile 3Quartile 4UA < 6.86.8 ≤ UA < 7.67.6 ≤ UA < 8.5UA ≥ 8.5Number297332273312Number of events (n)80554243Unadjusted HR (95% CI)1.94 (1.33 to 2.81)1.08 (0.72 to 1.61)1.0 (Reference)0.89(0.58 to 1.36)P value < 0.0010.710.61Adjusted HR (95% CI)1.89 (1.14 to 3.10)1.21 (0.70 to 2.06)1.0 (Reference)1.21(0.70 to 2.10)P value < 0.0010.70.15Adjusted for age, dialysis vintage, sex, diabetes mellitus, body mass index, systolic blood pressure, hemoglobin, albumin, creatinine, potassium, calcium, phosphate, c-reactive protein, Kt/V, past history of cardiovascular disease event, use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, use of statins, use of vitamin D receptor agonists, use of anti-platelet drugs, and use of anti-hyperuricemic drugsUA uric acid, HR hazard ratio, CI confidence intervalRestricted cubic spline curve of serum uric acid levels for all-cause mortality.
Source: Serum uric acid levels and mortality. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In this prospective multicenter cohort study, hemodialysis patients were recruited at the dialysis outpatient units of 15 medical institutions in Tokyo, Japan [, ].
Source: Methods.
In this prospective multicenter cohort study, hemodialysis patients were recruited at the dialysis outpatient units of 15 medical institutions in Tokyo, Japan [, ].
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients
Cohort study · Human Cell · 2020
Original publication title
Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Electronic supplementary material
The online version of this article (10.1007/s13577-020-00342-w) contains supplementary material, which is available to authorized users.
Source: Electronic supplementary materialAuthors’ abstract
Dysfunctional variants of ATP-binding cassette transporter subfamily G member 2 (ABCG2), a urate transporter in the kidney and intestine, are the major causes of hyperuricemia and gout. A recent study found that ABCG2 is a major transporter of uremic toxins; however, few studies have investigated the relationship between ABCG2 gene polymorphisms and mortality. This prospective cohort study of 1214 hemodialysis patients investigated the association between serum uric acid levels and ABCG2 genotype and mortality. Genotyping of dysfunctional ABCG2 variants, Q126X (rs72552713) and Q141K (rs2231142), was performed using the patients’ DNA.
During the study period, 220 patients died. Lower serum uric acid levels were associated with higher mortality (hazard ratio [HR] 1.89, 95% confidence interval [CI] 1.14 to 3.10, P ≤ 0.001). ABCG2 dysfunction, estimated by genetic variants, had a significant positive association with serum uric acid levels (full function: 7.4 ± 1.2 mg/dl, 3/4 function: 7.9 ± 1.3 mg/dl, 1/2 function: 8.2 ± 1.4 mg/dl, ≤ 1/4 function: 8.7 ± 1.3 mg/dl, P ≤ 0.001). This association remained significant on multiple regression analysis.
The Cox proportional hazard analysis indicated that the ABCG2 ≤ 1/4 function type was significantly associated with higher mortality (HR 6.66, 95% CI 2.49 to 17.8, P ≤ 0.001) than the other function types. These results showed that ABCG2 plays a physiologically important role in uric acid excretion, and that ABCG2 dysfunction is a risk factor for mortality in hemodialysis patients.
Electronic supplementary material
The online version of this article (10.1007/s13577-020-00342-w) contains supplementary material, which is available to authorized users.
Publication and source details
Original title: Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients
Akio Nakashima; Kimiyoshi Ichida; Ichiro Ohkido; Keitaro Yokoyama; Hirotaka Matsuo; Yuki Ohashi; Tappei Takada; Akiyoshi Nakayama; Hiroshi Suzuki; Nariyoshi Shinomiya; Mitsuyoshi Urashima; Takashi Yokoo
Human Cell · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T17:57:12.737910+00:00
DOI: 10.1007/s13577-020-00342-w · PMC7324430